Skip to main content

Chelation Therapy

Chelation therapy uses medications that bind selected metals so they can be removed from the body.

It has an established role in the treatment of specific toxic-metal exposures and is used in the practice for selected patients after appropriate assessment and testing.

Book Online
Intravenous chelation solution prepared for a monitored clinic treatment

A targeted medical treatment

Where chelation fits

Chelating agents bind particular metals and allow more of them to be excreted. Different agents have different uses: a treatment appropriate for lead exposure is not automatically appropriate for mercury, arsenic or another metal.

The presence of a metal in a laboratory result does not by itself mean that chelation is needed. The concentration, exposure history, symptoms, timing, kidney function and expected benefit all matter. When treatment is justified, chelation can play an important role alongside removal of the exposure source and appropriate medical follow-up.

Overview of common sources and health effects of lead exposure

Concerned about lead exposure?

Learn about common sources, health effects and the testing used to assess lead exposure.

Read the lead toxicity guide

Assessment before treatment

A careful process from exposure to plan

Symptoms of metal exposure can overlap with many other conditions. Testing and treatment are therefore chosen around the exposure itself—not from symptoms alone.

01

Review the exposure

Your health history, work and home exposures, symptoms, medications and previous results help establish which metals and tests are relevant.

02

Select appropriate testing

Blood or urine testing may be used depending on the metal, the type of exposure and how recently it occurred. Results are interpreted in that context.

03

Address the source

Identifying and reducing an ongoing exposure is a central part of care. Chelation is not a substitute for removing the source.

04

Build and monitor the plan

When chelation is appropriate, the agent, dose, route and monitoring plan are selected for the specific metal and your health status.

How treatment works

The chelator is selected for the metal and the patient

EDTA is one chelating agent; other medications are used for other metals or clinical circumstances. Treatment may be intravenous or oral. The route and schedule depend on the agent, the exposure and the patient’s medical status.

Metal-specific selection

The laboratory findings and type of exposure guide the choice of chelating agent.

Baseline testing

Kidney function, blood counts, minerals and other tests may be reviewed before treatment.

Individualized dosing

Dose and frequency are adjusted to the chelator, test findings and clinical circumstances.

Ongoing monitoring

Symptoms, kidney function, hydration and relevant laboratory markers are followed during care.

What an appointment involves

Clear decisions before treatment begins

An initial consultation is used to review the suspected exposure, current symptoms, medical history, medications and any laboratory results you already have. Further testing can be arranged when it would help determine whether treatment is indicated or how it should be provided.

If chelation is suitable, the proposed agent, route, expected schedule, monitoring and costs are reviewed before proceeding. Some exposures require coordination with a family doctor, poison centre, medical toxicologist or emergency department.

Bring previous results when possible

Laboratory reports, a list of medications and supplements, and details about where and when the exposure may have occurred are all useful.

Safety and monitoring

Chelation requires appropriate screening and follow-up

Chelating agents can affect kidney function, fluid balance and essential minerals, and they can interact with a patient’s broader medical situation. The risks differ by medication, dose and route.

Before treatment

Review kidney and liver function, medications, pregnancy status, cardiovascular health and relevant laboratory findings.

During treatment

Use an appropriate infusion rate or oral schedule and monitor tolerance, hydration and any treatment-specific concerns.

After treatment

Repeat the relevant clinical and laboratory assessment before deciding whether additional treatment is warranted.

Discuss a possible metal exposure

Book a consultation to review the exposure, determine which testing is appropriate and discuss whether chelation belongs in your care plan.

Selected references

  1. Agency for Toxic Substances and Disease Registry. Lead medical management guidelines and clinical guidance on the treatment of lead exposure.
  2. Agency for Toxic Substances and Disease Registry. Clinician guidance for the assessment and management of arsenic exposure.